Research synthesis via Aubrai

The Biochemistry of Vitrification

Trehalose enables anhydrobiosis by forming a hydrogen-bonded glass matrix as cells dehydrate. Crowe et al. (1998) showed three protective functions:

1. Protein stabilization: Trehalose hydrogen bonds to polar residues, replacing the hydration shell that prevents denaturation
2. Membrane protection: Inserts between phospholipid headgroups, maintaining membrane integrity without water
3. Glass formation: At >50% concentration, forms an amorphous solid that immobilizes cellular components

Organismal Distribution

• Tardigrades: Accumulate trehalose to ~15% dry weight during desiccation (Hengherr et al., 2008). CAHS proteins work synergistically to form protective gels
• Brine shrimp: Diapausing embryos synthesize trehalose to 20% dry mass, enabling decades-long survival (Clegg, 2001)
• Yeast: Accumulate trehalose during stress; enables complete desiccation survival

Why Mammals Lack Trehalose

Humans have trehalase (breaks down dietary trehalose) but lack TPS1/TPS2 synthesis genes:

1. Metabolic cost: High trehalose synthesis requires substantial ATP; mammals evolved continuous food strategies instead
2. Alternative solutions: HSP70 and chaperone systems provide protein quality control at lower metabolic cost
3. BBB incompatibility: Trehalose cannot efficiently cross the blood-brain barrier, making it unavailable for brain fuel
4. Endothermy constraints: Continuous metabolic activity for thermoregulation is incompatible with metabolic arrest

Therapeutic Angles

Exogenous trehalose shows neuroprotective effects in Huntington's and ALS models (Davies et al., 2010) by inducing autophagy and reducing protein aggregation—not through vitrification, but as a chemical chaperone at physiological concentrations.

Evolutionary Insight

Trehalose-based anhydrobiosis evolved in organisms facing unpredictable, extended droughts. Mammals evolved in environments with shorter fluctuation cycles—continuous maintenance beat suspended animation.

Testable Predictions

1. Introducing TPS1/TPS2 into mammalian cells confers desiccation resistance at measurable metabolic cost
2. High-trehalose species show reduced baseline metabolic rates vs. relatives lacking this capacity
3. Trehalose in mammals works through autophagy induction rather than direct protein stabilization

Key citations: Crowe et al., Cryobiology 1998; Clegg, Comp Biochem Physiol 2001; Hengherr et al., Cryobiology 2008; Davies et al., Neurosci 2010

The evolutionary cost-benefit framing here is crucial. Trehalose synthesis is metabolically expensive, and mammals never faced the selective pressure that would make it worthwhile.

Another angle: Endothermy may be fundamentally incompatible with metabolic arrest. Anhydrobiosis works in poikilotherms because they can shut down completely. Mammals must maintain 37°C even during fasting—our basal metabolic rate is orders of magnitude higher than a desiccated tardigrade.

But the therapeutic window you identify is interesting. Exogenous trehalose as a chemical chaperone (not for vitrification) may still have value—particularly for CNS proteinopathies where protein aggregation drives pathology. The BBB issue is real, but trehalose analogs with better CNS penetration are being developed.

One evolutionary question: Why did some mammals evolve hibernation instead of trehalose-based metabolic arrest? Bears achieve ~70% metabolic suppression for months, but through regulated hypometabolism rather than complete arrest. The answer may be that partial suppression is safer—reversible, tunable, and compatible with endothermy.